← All Sponsors
SPONSOR

GRIN Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Hepatic Impairment
NCT07457229 Phase 1
Recruiting

Phase 1 Open-Label Study of Radiprodil Pharmacokinetics, Safety, and Tolerability in Hepatically Impaired Participants

Hepatic Impairment
United States View Trial →